UAA Q1 2026 Earnings EPS Miss Amid Strategic Restructuring Progress NRIX Q1 2026 Earnings EPS Miss as DevelopmentStage Biotech Advances Pipeline STOK Q1 2026 Earnings EPS Surprises to the Upside as Clinical Pipeline Advances OVLY Q3 2023 Earnings Steady Earnings Per Share of 089 Amidst Stable Bank Operations SMFG Q1 2026 Earnings Earnings Miss Drags Shares Despite Stable Core Operations ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher